Global Companion Diagnostics Market Outlook, 2020-2025: Breakdown for Devices, Kits and Assay

DUBLIN, June 15, 2020 /PRNewswire/ -- The "Global Companion Diagnostic Market By Technology (Nanostring Technology, Next-Generation sequencing, In-Situ Hybridization, Immunohistochemistry and Others), By Products, By Indication, By End-User, By Application, By Region, Competition, Forecast & Opportunities, 2025" report has been added to ResearchAndMarkets.com's offering.

http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

The Global Companion Diagnostic Market size was valued at USD 3 billion in 2019 and projected to grow at an impressive CAGR during the forecast period.

The key factor responsible for the growth of the companion diagnostic market is growing cases of cancer across the globe. Additionally, increase in requirement for targeted therapy is another major factor which is anticipated to bode well for the growth of the companion diagnostic market in the coming years. Moreover, rising number of clinical trials is further anticipated to bolster the market growth until 2025.

The market is segmented based on technology, products, indication, end-user, application, and region. Based on end-user, the market can be segmented into pharmaceutical & biotechnology companies, research laboratories, contract research organization and others. Out of which, the pharmaceutical & biotechnology companies dominated the market in terms of largest market share until 2019 and is further anticipated to be the fastest-growing application segment in the companion diagnostic market during the next five years as well.

This growth can be accredited to widespread use of companion diagnostics in such industries because of their increasing stronghold in the drug development sector as well as growing importance of companion diagnostic biomarkers. Additionally, surge in requirement for personalized medicines coupled with the high demand for targeted therapies for treatment of multiple diseases and disorders is further boosting the growth of the segment across the globe.

Major players operating in the Global Companion Diagnostic Market include NG Biotech, Agilent Technologies, Illumnia, Qiagen, Thermo Fisher Scientific, Roche, Molecular MD, Myriad Genetics, Foundation Medicine, Bayer, Genentech, Abbott, Novartis, Perkin Elmer, Luminex Corporation, Parexel, Quest Diagnostics, Genesys Diagnostics, Danaher, Siemens Healthcare, bioMerieux SA and others.

The companies operating in the Global Companion Diagnostic Market are focusing towards expanding their share in the market. For instance, these key players are making organic strategies such as new product launches & approvals, among others in order to enrich their consumer base.

Years considered for this report:

    --  Historical Years: 2015-2018
    --  Base Year: 2019
    --  Estimated Year: 2020
    --  Forecast Period: 2021-2025

Objective of the Study

    --  To analyse and forecast the market size of the Global Companion
        Diagnostic Market.
    --  To classify and forecast the Global Companion Diagnostic Market based on
        technology, products, indication, end-user, application, company and
        regional distribution.
    --  To identify drivers and challenges for the Global Companion Diagnostic
        Market.
    --  To examine competitive developments such as expansions, new product
        launches, mergers & acquisitions, etc., in the Global Companion
        Diagnostic Market.
    --  To conduct pricing analysis for the Global Companion Diagnostic Market.
    --  To identify and analyse the profile of leading players operating in the
        Global Companion Diagnostic Market.

Key Topics Covered

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Global Companion Diagnostic Market Outlook
4.1. Market Size & Forecast
4.1.1. By Value & Volume
4.2. Market Share & Forecast
4.2.1. By Technology (Nanostring Technology, Next-Generation sequencing, In-Situ Hybridization, Immunohistochemistry and Others)
4.2.2. By Products (Devices, Kits and assay)
4.2.3. By Indication (Oncology, Respiratory, Orthopedics and Others)
4.2.4. By End-User (Pharmaceutical & Biotechnology Companies, Research Laboratories, Contract research organization and others)
4.2.5. By Application (Drug Discovery, In-Vitro diagnostics and Others)
4.2.6. By Company (2019)
4.2.7. By Region
4.3. Market Attractiveness Index

5. Asia-Pacific Companion Diagnostic Market Outlook

6. Europe Companion Diagnostic Market Outlook

7. North America Companion Diagnostic Market Outlook

8. South America Companion Diagnostic Market Outlook

9. Middle East and Africa Companion Diagnostic Market Outlook


10. Market Dynamics
10.1. Drivers
10.2. Challenges

11. Market Trends & Developments

12. Competitive Landscape
12.1. Competition Outlook
12.2. Players Profiled (Leading Companies)
12.2.1. NG Biotech
12.2.2. Agilent Technologies
12.2.3. Illumnia
12.2.4. Qiagen
12.2.5. Thermo Fisher Scientific
12.2.6. Roche
12.2.7. Molecular MD
12.2.8. Myriad Genetics
12.2.9. Foundation Medicine
12.2.10. Bayer
12.2.11. Genentech
12.2.12. Abbott
12.2.13. Novartis
12.2.14. Perkin Elmer
12.2.15. Luminex Corporation
12.2.16. Parexel
12.2.17. Quest Diagnostics
12.2.18. Genesys Diagnostics
12.2.19. Danaher
12.2.20. Siemens Healthcare
12.2.21. bioMerieux SA

13. Strategic Recommendations

For more information about this report visit https://www.researchandmarkets.com/r/t1sai8

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-companion-diagnostics-market-outlook-2020-2025-breakdown-for-devices-kits-and-assay-301076698.html

SOURCE Research and Markets